Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;8(3):539–548. doi: 10.1111/j.1750-3639.1998.tb00176.x

Molecular Pathology of Fatal Familial Insomnia

Piero Parchi 1, Robert B Petersen 1, Shu G Chen 1, L Autilio‐Gambetti 1, Sabina Capellari 1, Lucia Monari 2, Pietro Cortelli 2, Pasquale Montagna 2, Elio Lugaresi 2, Pierluigi Gambetti 1,✉
PMCID: PMC8098344  PMID: 9669705

Abstract

Fatal familial insomnia (FFI) is linked to a mutation at codon 178 of the prion protein gene, coupled with the methionine codon at position 129, the site of a methionine/valine polymorphism. The D178N mutation coupled with the 129 valine codon is linked to a subtype of Creutzfeldt‐Jakob disease (CJD178) with a different phenotype. Two protease resistant fragments of the pathogenic PrP (PrPres), which differ in molecular mass, are associated with FFI and CJD178, respectively, suggesting that the two PrPres have different conformations and hence they produce different disease phenotypes. FFI transmission experiments, which show that the endogenous PrPres recovered in affected syngenic mice specifically replicates the molecular mass of the FFI PrPres inoculated and is associated with a phenotype distinct from that of the CJD178 inoculated mice, support this idea. The second distinctive feature of the FFI PrPres is the underrepresentation of the unglycosylated PrPresform. Cell models indicate that the underrepresentation of this PrPres form results from the PrP dys‐metabolism caused by the D178N mutation and not from the preferential conversion of the glycosylated forms. Codon 129 on the normal allele further modifies the FFI phenotype determining patient subpopulations of 129 homozygotes and heterozygotes: disease duration is generally shorter, insomnia more severe and histopathology more restricted to the thalamus in the homozygotes than in the heterozygotes The allelic origin of PrPres fails to explain this finding since in both cases FFI PrPres is expressed only by the mutant allele. Despite remarkable advances, many issues remain unsolved precluding full understanding of the FFI pathogenesis.

Full Text

The Full Text of this article is available as a PDF (155.8 KB).

Supported by: NIH grants AG08155, AG08992, and the Britton Fund.

References

  • 1. Baker HF, Poulter M, Crow TJ, Frith CD, Lofthouse R, Ridley RM, Collinge J. (1991) Amino acid polymorphism in human prion protein and age at death in inherited prion disease. Lancet 337: 1286. [DOI] [PubMed] [Google Scholar]
  • 2. Bessen RA, Marsh RF (1992). Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66: 2096–2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Brown P, Kenney K, Little B, Ironside J, Will R, Cervenakova L, Bjork RJ, San Martin RA, Safar J, Roos R, Haltia M, Gibbs CJ, Jr , and Gajdusek DC. (1995). Intracerebral distribution of infectious amyloid protein in spongiform encephalopathy. Ann Neurol 38: 245–253. [DOI] [PubMed] [Google Scholar]
  • 4. Bruce ME. Strain typing studies of scrapie and BSE (1996). In: Methods in Molecular Medicine: Prion Diseases Baker H, Ridley RM (Eds), Humana Press Inc., pp. 223–236. [Google Scholar]
  • 5. Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989). Prion protein biosynthesis in scrapie‐infected and uninfected neuroblastoma cells. J Virol 63: 175–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio‐Gambetti L (1995). Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270: 19173–19180. [DOI] [PubMed] [Google Scholar]
  • 7. Chen SG, Parchi P, Brown P, Capellari S, Zou W, Cochran EJ, Vnencak‐Jones CL, Julien J, Vital C, Mikol J, Lugaresi E, Autilio‐Gambetti L, Gambetti P (1997). Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med 3: 1009–1015. [DOI] [PubMed] [Google Scholar]
  • 8. Cortelli P, Perani D, Parchi P, Grassi F, Montagna P, De Martin M, Castellani R, Tinuper P, Gambetti P, Lugaresi E, Fazio F (1997). Cerebral metabolism in fatal familial insomnia: Relation to duration, neuropathology, and distribution of protease‐resistant prion protein. Neurology 49: 126–133. [DOI] [PubMed] [Google Scholar]
  • 9. Dlouhy SR, Hsiao K, Farlow MR, Foroud T, Conneally PM, Johnson P, Prusiner SB, Hodes ME, Ghetti B (1992). Linkage of the Indiana kindred of Gerstmann‐Sträussler‐Scheinker disease to the prion protein gene. Nat Genet 1: 64–67. [DOI] [PubMed] [Google Scholar]
  • 10. Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996). Insoluble wild‐type and protease‐resistant mutant prion protein in brains of patients with inherited prion diseases. Nat Med 2: 59–64. [DOI] [PubMed] [Google Scholar]
  • 11. Goldfarb LG, Brown P, Goldgaber D (1989). Patients with Creutzfeldt‐Jakob disease and kuru lack the mutation in the PRNP gene found in Gerstmann‐Sträussler Scheinker syndrome, but they show a different double‐allele mutation in the same gene. Am J Hum Genet 45: (Suppl.): A189. [Google Scholar]
  • 12. Goldfarb LG, Haltia M, Brown P, Nieto A, Kovanen J, McCombie WR, Trapp S, Gajdusek DC (1991). New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt‐Jakob kindred. Lancet 337: 425. [DOI] [PubMed] [Google Scholar]
  • 13. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendlebury WW, Haltia M, Willis PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio‐Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P (1992). Fatal familial insomnia and Familial Creutzfeldt Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258: 806–808. [DOI] [PubMed] [Google Scholar]
  • 14. Jarius C, Hainfellner JA, Kitamoto T, Parchi P, Gambetti P, Budka H (1998). Familial Creutzfeldt‐Jakob disease with PRNP codon E200K mutation: valine homozygosity in codon 129 and type 2 PrPres (in press). [PubMed] [Google Scholar]
  • 15. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P (1986). Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. New Engl J Med 315: 997–1003. [DOI] [PubMed] [Google Scholar]
  • 16. Manetto V, Medori R, Cortelli P, Montagna P, Baruzzi A, Hauw JJ, Rancurel G, Vanderhaeghen JJ, Mailleux P, Bugiani O, Tagliavini F, Bouras C, Rizzuto N, Lugaresi E, Gambetti P (1992). Fatal familial insomnia: Clinical and pathological study of five new cases. Neurology 42: 312–319. [DOI] [PubMed] [Google Scholar]
  • 17. Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw JJ, Ott J, Lugaresi E, Autilio‐Gambetti L, Gambetti P. Fatal familial insomnia is a prion disease with a mutation at codon 178 of the prion protein gene. New Engl J Med 326: 444–449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J, Gray F, Cortelli P, Montagna P, Ghetti B, Goldfarb LG, Gajdusek DC, Lugaresi E, Gambetti P, Autilio‐Gambetti L (1994). Fatal Familial Insomnia and familial Creutzfeldt‐Jakob disease: Different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA, 91: 2839–2842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Nieto A, Goldfarb LG, Brown P, McCombie WR, Trapp S, Asher DM, Gajdusek DC (1991). Codon 178 mutation in ethnically diverse Creutzfeldt‐Jakob disease families. Lancet 337:622–623. [DOI] [PubMed] [Google Scholar]
  • 20. Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991). Homozygous prion protein genotype predisposes to sporadic Creutzfeldt‐Jakob disease. Nature 352: 340–342. [DOI] [PubMed] [Google Scholar]
  • 21. Palmer MS, Mahal SP, Campbell TA, Hill AF, Sidle KC, Laplanche JL, Collinge J (1993). Deletions in the prion protein gene are not associated with CJD. Hum Mol. Genet. 2: 541–544. [DOI] [PubMed] [Google Scholar]
  • 22. Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, Manetto V, Vnencak‐Jones CL, McLean MJ, Sheller JR, Lugaresi E, Autilio‐Gambetti L, Gambetti P (1995). Regional distribution of protease‐resistant prion protein in Fatal Familial Insomnia. Ann Neurol 38: 21–29. [DOI] [PubMed] [Google Scholar]
  • 23. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ, Petersen RB, Gambetti P (1996). Molecular basis of phenotypic variability in sporadic Creutzfeldt‐Jakob disease. Ann Neurol 39: 767–778. [DOI] [PubMed] [Google Scholar]
  • 24. Parchi P, Capellari S, Chen SG, Ghetti B, Mikol J, Vital C, Cochran E, Trojanowski JQ, Dickson DW, Petersen RB, Gambetti P (1996). Similar posttranslational modifications of the prion protein in familial, sporadic and iatro‐genic Creutzfeldt‐Jakob disease. Soc Neurosci Abstr 711.
  • 25. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A, Kretzschmar H (1997). Typing prion isoforms. Nature 386: 232–234. [DOI] [PubMed] [Google Scholar]
  • 26. Parchi P, Piccardo P, Gambetti P, Ghetti B. Human Prion Diseases (1998). In: Progress in Pathology 4, Kirkham N, and Lemoine NR. Churchill Livingstone, Edimburgh . pp 39–77. [Google Scholar]
  • 27. Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P (1996). Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271, 12661–12668. [DOI] [PubMed] [Google Scholar]
  • 28. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG (1983). Scrapie prions aggregate to form amyloid‐like birefringent rods. Cell 35: 349–358. [DOI] [PubMed] [Google Scholar]
  • 29. Riek R, Liemann S, Wider G, Billeter M, Hornemann S, Glockshuber R, Wuthrick K. Prion Protein NMR structure and familial human transmissible spongiform encephalopathies. J Mol Biol (in press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Silvestrini MC, Cardone F, Maras B, Pucci P, Barra D, Brunori M, Pocchiari M (1997). Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt‐Jakob disease patients. Nat Med 3: 521–525. [DOI] [PubMed] [Google Scholar]
  • 31. Tagliavini F, Prelli F, Porro M, Rossi G, Giaccone G, Farlow MR, Dlouhy SR, Ghetti B, Bugiani O, Frangione B. (1994) Amyloid fibrils in Gerstmann‐Straussler‐Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79: 695–703. [DOI] [PubMed] [Google Scholar]
  • 32. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB (1995). Cholesterol depletion and modification of COOH‐terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 129: 121–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB (1996). Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 214: 2079–2082. [DOI] [PubMed] [Google Scholar]
  • 34. Young K, Clark HB, Piccardo P, Dlouhy SR, Ghetti B (1997). Gerstmann‐Straussler‐Scheinker disease with the PRNP P102L mutation and valine at codon 129. Mol Brain Res 44: 147–150. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES